Literature DB >> 12900297

Schizophrenia, IV: neuregulin-1 in the human brain.

Amanda Law.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900297     DOI: 10.1176/appi.ajp.160.8.1392

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan.

Authors:  Mamoona Naz; Maria Riaz; Mahjabeen Saleem
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

2.  The genetics of schizophrenia.

Authors:  Mohd Razali Salleh
Journal:  Malays J Med Sci       Date:  2004-07

3.  Downregulation of neuregulin 1-ErbB4 signaling and antidepressant properties of ketamine: ErbB4 expressing pyramidal neurons may play a role.

Authors:  Hans-Gert Bernstein; Gerburg Keilhoff; Johann Steiner; Gregor Laube; Bernhard Bogerts
Journal:  J Mol Neurosci       Date:  2014-05-30       Impact factor: 3.444

4.  Shared gene expression alterations in schizophrenia and bipolar disorder.

Authors:  Ling Shao; Marquis P Vawter
Journal:  Biol Psychiatry       Date:  2008-01-11       Impact factor: 13.382

5.  Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.

Authors:  Kari Hänninen; Heikki Katila; Marika Saarela; Riikka Rontu; Kari M Mattila; Meng Fan; Mikko Hurme; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

6.  Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response.

Authors:  Jacqueline F Donoghue; Lauren T Kerr; Naomi W Alexander; Sameer A Greenall; Anthony B Longano; Nicholas G Gottardo; Rong Wang; Viviane Tabar; Timothy E Adams; Paul S Mischel; Terrance G Johns
Journal:  Cancers (Basel)       Date:  2018-07-25       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.